|Horizon||30 Days Login to change|
XTL Biopharmaceutica Market Sensitivity
|As returns on market increase, returns on owning XTL Biopharmaceutica are expected to decrease at a much smaller rate. During bear market, XTL Biopharmaceutica is likely to outperform the market.One Month Beta |Analyze XTL Biopharmaceuticals Demand TrendCheck current 30 days XTL Biopharmaceutica correlation with market (DOW)|
β = -0.616
XTL Biopharmaceuticals Technical Analysis
XTL Biopharmaceutica Projected Return Density Against MarketAssuming 30 trading days horizon, XTL Biopharmaceuticals Ltd has beta of -0.616 . This means as returns on benchmark increase, returns on holding XTL Biopharmaceutica are expected to decrease at a much smaller rate. During bear market, however, XTL Biopharmaceuticals Ltd is likely to outperform the market. In addition to that, XTL Biopharmaceuticals Ltd has an alpha of 2.3198 implying that it can potentially generate 2.3198% excess return over DOW after adjusting for the inherited market risk (beta).
Predicted Return Density
XTL Biopharmaceutica Return VolatilityXTL Biopharmaceuticals Ltd accepts 10.2926% volatility on return distribution over the 30 days horizon. DOW inherits 1.0373% risk (volatility on return distribution) over the 30 days horizon.